Improvement in Liver Fibrosis in Patients with Hepatitis C Who Respond to Interferon Treatment
Journal: Annals of Internal Medicine (2000)

Summaries for Patients4 April 2000Improvement in Liver Fibrosis in Patients with Hepatitis C Who Respond to Interferon TreatmentSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-132-7-200004040-00036 SectionsAboutFull Text ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail What is the problem and what is known about it so far?When viewed under a microscope, liver tissue damaged by chronic infection with the hepatitis C virus shows inflammation. As the disease progresses, scarring (fibrosis) occurs. This scarring can eventually cause a condition called cirrhosis, which can lead to liver failure. In some patients, treatment with a drug called interferon eliminates the virus. Doctors can now measure the amount of virus in patients' blood. Patients who have no measurable amount of virus in their blood 6 months after interferon treatment are generally considered to have responded well to the ... Author, Article, and Disclosure InformationAffiliations: The summary below is from the full report titled “Histologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon Therapy.”. It is in the 4 April 2000 issue of Annals of Internal Medicine (volume 132, pages 517-524). The authors are Y. Shiratori, F. Imazeki, M. Moriyama, M. Yano, Y. Arakawa, O. Yokosuka, T. Kuroki, S. Nishiguchi, M. Sata, G. Yamada, S. Fujiyama, H. Yoshida, and M. Omata.Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoHistologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon Therapy Yasushi Shiratori , Fumio Imazeki , Mitsuhiko Moriyama , Michitami Yano , Yasuyuki Arakawa , Osamu Yokosuka , Tetsuo Kuroki , Shuhei Nishiguchi , Michio Sata , Gotarou Yamada , Shigetoshi Fujiyama , Haruhiko Yoshida , and Masao Omata Metrics Cited byHistological changes in patients who developed hepatocellular carcinoma after hepatitis�C virus eradication by interferon‑based therapyChronic hepatitis C: This and the new era of treatmentLong-Term Follow-Up of Chronic Hepatitis C Patients Treated with Interferon-Alpha: Risk of Cirrhosis and Hepatocellular Carcinoma in a Single Center over 10 YearsPrediction of Hepatocellular Carcinoma Incidence Risk by Ultrasound ElastographyNoninvasive Diagnosis of Liver Fibrosis: Utility of Data Mining of Both Ultrasound Elastography and Serological Findings to Construct a Decision TreeUltrasound Elastography Correlates Treatment Response by Antiviral Therapy in Patients with Chronic Hepatitis C 4 April 2000Volume 132, Issue 7Page: 517KeywordsBiopsyChronic hepatitis CDrugsFibrosisHepatitis CInflammationInterferonsLiverLiver fibrosisPatients ePublished: 15 August 2000 Issue Published: 4 April 2000 Copyright & PermissionsCopyright © 2000 by American College of Physicians. All Rights Reserved.Loading ...